Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$5.4MFederal grants as PI13 awards
0Patents grantedNone matched
72Papers1,184 citations
Federal awards and patents by year
AwardsPatents
13 awards · $5.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 20, 2024 | NIH | SBIR Phase I Chemically Induced Dimerization Systems for High Throughput Enzyme Assays | $271K | Bellbrook Labs, LLC |
| Feb 9, 2022 | NIH | SBIR Phase II Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases | $832K | Bellbrook Labs, LLC |
| Feb 11, 2021 | NIH | SBIR Phase II Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases | $989K | Bellbrook Labs, LLC |
| Sep 11, 2020 | NIH | SBIR Phase I Discovery of TREX1 Antagonists for Cancer Immunotherapy | $300K | Bellbrook Labs, LLC |
| Aug 8, 2019 | NIH | SBIR Phase II HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer | $329K | Bellbrook Labs, LLC |
| Jun 12, 2019 | NIH | SBIR Phase I Discovery of cGAS Inhibitors for Interferon-Driven Autoimmune Diseases | $300K | Bellbrook Labs, LLC |
| Apr 11, 2019 | NIH | SBIR Phase II HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer | $416K | Bellbrook Labs, LLC |
| Apr 26, 2017 | NIH | SBIR Phase I HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer | $289K | Bellbrook Labs, LLC |
| Apr 24, 2017 | NIH | SBIR Phase II Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery | $390K | Bellbrook Labs, LLC |
| Sep 19, 2016 | NIH | SBIR Phase I Pharmacological Validation of GIV/Girdin, a Guanine Nucleotide Exchange Factor, for Liver Fibrosis | $353K | Bellbrook Labs, LLC |
| Sep 13, 2016 | NIH | STTR Phase I Streamlining HTS Assay Development through Direct Selection of Structure-Switching Aptamers | $235K | Bellbrook Labs, LLC |
| Apr 26, 2016 | NIH | SBIR Phase II Riboswitch Based Methyltransferase HTS Assay for Epigenetic Drug Discovery | $470K | Bellbrook Labs, LLC |
| May 6, 2015 | NIH | STTR Phase I Axonal Transport HTS Platform for Neurodegeneration Drug Discovery | $225K | Bellbrook Labs, LLC |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#240
Awards as PI#72
Patents#273
Companies
- Bellbrook Labs, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.